Abstract:OBJECTIVE:Kawasaki disease (KD) complicated with coronary artery lesion (CAL) seriously threatens survival quality and life of patients, suggesting that it is very important to early predict the risk of CAL and to early diagnose the disease. Nevertheless, up to now there has been no specific clinical biochemical marker for it because of the poor understanding of the pathological process of KD with CAL. Matrix metalloproteinases (MMPs) and their specific tissue inhibitor of metalloproteinases (TIMPs) play an important role in arterial wall extracellular matrix breakdown and remodeling and are involved in CAL in other diseases. In the present study the practical value of serum MMP-9 and TIMP-1 levels in the prediction and early diagnosis of CAL in KD patients was investigated.METHODS:All subjects were from Chinese population. Serum levels of MMP-9 and TIMP-1 were measured by rapid one-step sandwich enzyme immunoassay in 59 KD patients including 15 with CAL and 44 without CAL by 2 D-echocardiography and coronary angiography, and 20 normal healthy children as controls. Blood samples of patients were obtained before and after intravenous immunoglobulin (IVIG) treatment in acute stage, subacute stage and convalescent stage as well. Serum MMP-9 and TIMP-1 levels and the ratio of MMP-9/TIMP-1 were compared by statistical method in KD patients and controls, as well as in KD with CAL and without CAL.RESULTS:In acute stage serum MMP-9 and TIMP-1 levels and the ratio of MMP-9/TIMP-1 were higher (P < 0.01) in patients with KD than those in healthy children. After IVIG treatment in KD patients serum MMP-9 level and the ratio of MMP-9/TIMP-1 decreased (P < 0.01). Before IVIG treatment serum MMP-9 level and the ratio of MMP-9/TIMP-1 were higher (P < 0.01) in patients with CAL than those in patients without CAL, and in acute stage after IVIG treatment serum MMP-9 level of KD patients with CAL was still higher than that of KD patients without CAL.CONCLUSION:In acute stage of KD serum MMP-9 level and the ratio of MMP-9/TIMP-1 were higher in patients with CAL than those in patients without CAL, suggesting that during acute phase of KD the great increase in serum MMP-9 and the imbalance of the MMP-9/TIMP-1 ratio might be high risk factors of KD coronary artery lesion. Therefore, the measurement of serum MMP-9 and TIMP-1 might be of important clinical value in the prediction and the early diagnosis of KD with coronary artery lesion.

Changes of Myeloid Related Protein-8/Myeloid Related Protein-14 Expressions in Children with Kawasaki Disease

Changes in CD_(69),CD_(25) and HLA-DR Expressions in Peripheral Blood T Cells in Kawasaki Disease

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease.

Changes of Serum G-CSF,IL-8 and PBN in Children with Kawasaki Disease and Coronary Artery Lesions

Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment]

Changes of Serum Interleukin-6,Interleukin-8 Levels and Their Associations with Coronary Artery Lesions in Children with Kawasaki Disease

Serum Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Children with Kawasaki Disease

A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.

Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions

Molecular Basis of Coronary Artery Dilation and Aneurysms in Patients with Kawasaki Disease Based on Differential Protein Expression.

Plasma miR-181a as a Candidate Diagnostic Biomarker for Kawasaki Disease Patients with Coronary Artery lesions

Leukocyte proteomics coupled with serum metabolomics identifies novel biomarkers and abnormal amino acid metabolism in Kawasaki disease

The Value of Measuring CD62P and VEGF Levels in Kawasaki Disease

Telomerase Expression in Peripheral Blood Mononuclear Cells in Children with Acute Kawasaki Disease

Screening of Differentially Expressed Genes Associated with Kawasaki Disease by Microarray Analysis.

Serum Levels of Vascular Endothelial Growth Factor in Children With Kawasaki Disease

[Clinical Value of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 for the Prediction and Early Diagnosis of Coronary Artery Lesion in Patients with Kawasaki Disease].

Over Expression of CD15 Antigen in Peripheral Blood in Kawasaki Disease

Identification and Validation of Differential Expression of Mir-455-5p in Plasma of Children with Kawasaki Disease

Clinical Study of Detecting C-reaction Protein,Immunoglobulin and Platelet in Children with Kawasaki Disease